![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 24, 2004 9:54:27 AM
++++++++++++++++++
http://www.clinicaltrialscompliance.com/content.cfm?content_id=35951
+++++++++++++++++++++++++++++ And text from link++++++++++
Clinical Trials Weekly
Week of November 04, 2003
FDA looking for information on interplay of drugs and genes
Volume: 0
Issue: 0
The FDA is asking drug companies to share information with them on how various drugs might interact with the DNA of individual patients, according to the Associated Press (AP). The study of gene and medicine interactions is called pharmacogenomics. The FDA is currently looking to increase its access to pharmacogenomic data by requiring companies to submit some information when they are seeking approval of a new medication. In other cases the FDA will ask companies to submit data on a voluntary basis. The information will be used to "keep up with the new field," the agency's drug chief, Dr. Janet Woodcock told the AP.
+++++++++++++++++++++++++++++++++++
Stakddek. I missed it. Sorry if I'm rehashing old ground.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM